focusing on adult vaccinations will be critical for a healthy population as the overall population, virtual attendants were told last wednesday at a media briefing hosted by glaxosmithkline (gsk), the pharmaceutical company that purchased pfizer’s consumer health business in 2018.
by 2050, the number of adults over 60 years of age will drastically
rise worldwide
, including 35 per cent of citizens in europe and 28 per cent in north america, according to the
united nations department of economic and social affairs
. this statistic that has some
economists warning
of surges in health- care spending and a decline in the available workforce.
the key to ensuring that health care and other services remain operational is to help citizens remain stay healthier later on in life, said mark doherty, senior manager at gsk global medical affairs. using vaccines to prevent disease is part of this strategy, as illnesses not only have an impact while we’re sick, but can also have far-reaching consequences that can cause disability or illness later on. for example, the risk of developing
shingles
after a bout of chickenpox, or developing pneumonia while having the flu.
‘a culture of vaccination’
“more than the obvious, when you have a culture of vaccination throughout your life, you prevent not only the disease that you’re aiming for with that specific vaccine, but also you prevent a lot of other conditions and diseases not related to that vaccine,” said dr. rodrigo schrage lins, president of the
society of infectious diseases of the state of rio de janeiro
.